Integrated Quality of Care System (SIC)

icono DM2


Comparative between states and Jurisdictions
    < Back
Comparison between states is shown by default. For more details, select your state and Jurisdiction.
State: Jurisdiction:  
Type of patient:

Characteristics of people living with Dyslipidemia (DLP)

N = 520,244 (Date of update – Abr 21 2019 12:06AM)

Distribution by age group and gender

Of all people living with DLP:
386,653 (74.3%)  are women
133,591 (25.7%)  are men
Distribution by comorbidity

Of all people living with DLP:
74,146 (14.3%) only have DLP 69,296 (13.3%) have diabetes mellitus
20,410 (3.9%) have HBP 24,215 (4.7%) have obesity
332,178 (63.9%) have MS  

Quality of care granted

% with at least medical consultation
[in the last 2 months]
% with LDL measurement
[in the last medical consultation]

Control of disease

% patients with at least one measurement of DLP

of patients with DLP  405,686(78.0%) have at least one measurement of LDL in the SIC
Distribution of patients by DLP result

Of all patients with LDL record:
220,229 ( 54.3% ) with LDL < 100
185,457 ( 45.7% ) with LDL >= 100

Treatment prescribed to patients with DLP

Since more than one medication may be prescribed to individual patients, the sum of medications may be greater than 100.
Of all people with DLP with prescription in their last visit ( 474,198):
46.6% are prescribed Pravastatin
68.9% are prescribed Bezafibrate
12.7% are prescribed Atorvastatin, simvastatin, fluvastatin, ezetimibe and Ezetimibe-Simvastatin